Stimulation of the STING pathway has the capacity to bolster host defenses against infectious agents, facilitate tumor suppression, and potentially provide clinical advantages for individuals battling viral hepatitis and advanced-stage HCC. Here, STING1 is linked to hepatocellular carcinoma.